Somatostatin therapy protects porcine livers in small-for-size liver transplantation

American Journal of Transplantation

Volumn 14, Issue 8, 2014, Pages 1806-1816

  Hessheimer, A J ^a   Escobar, B ^b   Munoz J ^a   Flores, E ^a   Gracia Sancho, J ^a   Taura P ^b   Fuster, J ^a   Rimola, A ^a   Garcia Valdecasas J C ^a   Fondevila, C ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Hepatic stellate cell; living donor; pig; portal vein flow; split

Indexed keywords

INFUSION FLUID; SOMATOSTATIN; HORMONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; ENDOTHELIUM CELL; GRAFT RECIPIENT; HUMAN; HUMAN CELL; HYPOTHESIS; IN VITRO STUDY; LIVER CELL DAMAGE; LIVER METABOLISM; LIVER REGENERATION; LIVER TRANSPLANTATION; MALE; NONHUMAN; PORCINE MODEL; PORTAL VEIN BLOOD FLOW; PRIORITY JOURNAL; RAT; REPERFUSION; SMALL FOR SIZE LIVER TRANSPLANTATION; STELLATE CELL; SWINE; ANIMAL; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; GRAFT SURVIVAL; HEMODYNAMICS; LIVER; ORGAN SIZE; PATHOLOGY; PERFUSION; PORTAL VEIN; POSTOPERATIVE PERIOD; REGENERATION;

ANIMALS; CELLS, CULTURED; ENDOTHELIAL CELLS; GRAFT SURVIVAL; HEMODYNAMICS; HEPATIC STELLATE CELLS; HORMONES; HUMANS; LIVER; LIVER TRANSPLANTATION; MALE; ORGAN SIZE; PERFUSION; PORTAL VEIN; POSTOPERATIVE PERIOD; REGENERATION; REPERFUSION; SOMATOSTATIN; SWINE;

EID: 84904605899     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12758     Document Type: Article

References (54)

1. Dahm F, Georgiev P, Clavien PA., Small-for-size syndrome after partial liver transplantation: Definition, mechanisms of disease and clinical implications. Am J Transplant 2005; 5: 2605-2610.
2. Imura S, Shimada M, Ikegami T, Morine Y, Kanemura H., Strategies for improving the outcomes of small-for-size grafts in adult-to-adult living-donor liver transplantation. J Hepatobiliary Pancreat Surg 2008; 15: 102-110.
3. Heaton N., Small-for-size liver syndrome after auxiliary and split liver transplantation: Donor selection. Liver Transpl 2003; 9: S26-S28.
4. Fondevila C, Hessheimer AJ, Taura P, et al. Portal hyperperfusion: Mechanism of injury and stimulus for regeneration in porcine small-for-size transplantation. Liver Transpl 2010; 16: 364-374.
5. Hessheimer AJ, Fondevila C, Taura P, et al. Decompression of the portal bed and twice-baseline portal inflow are necessary for the functional recovery of a "small-for-size" graft. Ann Surg 2011; 253: 1201-1210.
6. Kiuchi T, Onishi Y, Nakamura T., Small-for-size graft: Not defined solely by being small for size. Liver Transpl 2010; 16: 815-817.
7. Bosch J, Kravetz D, Rodes J., Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: Comparison with vasopressin. Gastroenterology 1981; 80: 518-525.
8. Cirera I, Feu F, Luca A, et al. Effects of bolus injections and continuous infusions of somatostatin and placebo in patients with cirrhosis: A double-blind hemodynamic investigation. Hepatology 1995; 22: 106-111.
9. Chatila R, Ferayorni L, Gupta T, Groszmann RJ., Local arterial vasoconstriction induced by octreotide in patients with cirrhosis. Hepatology 2000; 31: 572-576.
10. Wiest R, Tsai MH, Groszmann RJ., Octreotide potentiates PKC-dependent vasoconstrictors in portal-hypertensive and control rats. Gastroenterology 2001; 120: 975-983.
11. Kravetz D, Bosch J, Arderiu MT, et al. Effects of somatostatin on splanchnic hemodynamics and plasma glucagon in portal hypertensive rats. Am J Physiol 1988; 254 (3 Pt 1): G322-G328.
12. Pizcueta MP, Garcia-Pagan JC, Fernandez M, Casamitjana R, Bosch J, Rodes J., Glucagon hinders the effects of somatostatin on portal hypertension. A study in rats with partial portal vein ligation. Gastroenterology 1991; 101: 1710-1715.
13. Sieber CC, Mosca PG, Groszmann RJ., Effect of somatostatin on mesenteric vascular resistance in normal and portal hypertensive rats. Am J Physiol 1992; 262 (2 Pt 1): G274-G277.
14. Stoyanova II, Gulubova MV., Immunocytochemical study on the liver innervation in patients with cirrhosis. Acta Histochem 2000; 102: 391-402.
15. Reynaert H, Vaeyens F, Qin H, et al. Somatostatin suppresses endothelin-1-induced rat hepatic stellate cell contraction via somatostatin receptor subtype 1. Gastroenterology 2001; 121: 915-930.
16. Reynaert H, Rombouts K, Vandermonde A, et al. Expression of somatostatin receptors in normal and cirrhotic human liver and in hepatocellular carcinoma. Gut 2004; 53: 1180-1189.
17. Vanheule E, Geerts AM, Reynaert H, et al. Influence of somatostatin and octreotide on liver microcirculation in an experimental mouse model of cirrhosis studied by intravital fluorescence microscopy. Liver Int 2008; 28: 107-116.
18. Fondevila C, Hessheimer AJ, Flores E, et al. Step-by-step guide for a simplified model of porcine orthotopic liver transplant. J Surg Res 2011; 167: e39-e45.
19. Hopkins HA, Campbell HA, Barbiroli B, Potter VR., Thymidine kinase and deoxyribonucleic acid metabolism in growing and regenerating livers from rats on controlled feeding schedules. Biochem J 1973; 136: 955-966.
20. Marrone G, Russo L, Rosado E, et al. The transcription factor KLF2 mediates hepatic endothelial protection and paracrine endothelial-stellate cell deactivation induced by statins. J Hepatol 2013; 58: 98-103.
21. Chou CK, Ho LT, Ting LP, et al. Selective suppression of insulin-induced proliferation of cultured human hepatoma cells by somatostatin. J Clin Invest 1987; 79: 175-178.
22. Gracia-Sancho J, Russo L, Garcia-Caldero H, Garcia-Pagan JC, Garcia-Cardena G, Bosch J., Endothelial expression of transcription factor Kruppel-like factor 2 and its vasoprotective target genes in the normal and cirrhotic rat liver. Gut 2011; 60: 517-524.
23. Man K, Lo CM, Ng IO, et al. Liver transplantation in rats using small-for-size grafts: A study of hemodynamic and morphological changes. Arch Surg 2001; 136: 280-285.
24. Tian Y, Jochum W, Georgiev P, Moritz W, Graf R, Clavien PA., Kupffer cell-dependent TNF-alpha signaling mediates injury in the arterialized small-for-size liver transplantation in the mouse. Proc Natl Acad Sci USA 2006; 103: 4598-4603.
25. Cheng Q, Ng KT, Fan ST, et al. Distinct mechanism of small-for-size fatty liver graft injury-Wnt4 signaling activates hepatic stellate cells. Am J Transplant 2010; 10: 1178-1188.
26. Reynaert H, Rombouts K, Jia Y, et al. Somatostatin at nanomolar concentration reduces collagen I and III synthesis by, but not proliferation of activated rat hepatic stellate cells. Br J Pharmacol 2005; 146: 77-88.
27. Xu X, Man K, Zheng SS, et al. Attenuation of acute phase shear stress by somatostatin improves small-for-size liver graft survival. Liver Transpl 2006; 12: 621-627.
28. Feng ZY, Xu X, Wu LJ, Wu J, Zhu SM, Zheng SS., Downregulation of endothelin-1 by somatostatin improves liver function of recipients undergoing adult-to-adult living donor liver transplantation. Chin Med J (Engl) 2010; 123: 1961-1966.
29. Avgerinos A, Viazis N, Vlachogiannakos J, et al. Two different doses and duration schedules of somatostatin -14 in the treatment of patients with bleeding oesophageal varices: A non-randomised controlled study. J Hepatol 2000; 32: 171-172.
30. de Franchis R., Somatostatin, somatostatin analogues and other vasoactive drugs in the treatment of bleeding oesophageal varices. Dig Liver Dis 2004; 36 (Suppl 1): S93-100.
31. Pinter E, Helyes Z, Szolcsanyi J., Inhibitory effect of somatostatin on inflammation and nociception. Pharmacol Ther 2006; 112: 440-456.
32. Kalia M, Fuxe K, Agnati LF, Hokfelt T, Harfstrand A., Somatostatin produces apnea and is localized in medullary respiratory nuclei: A possible role in apneic syndromes. Brain Res 1984; 296: 339-344.
33. Chen ZB, Hedner T, Hedner J., Local application of somatostatin in the rat ventrolateral brain medulla induces apnea. J Appl Physiol 1990; 69: 2233-2238.
34. Murray F, Bell D, Kelso EJ, Millar BC, McDermott BJ., Positive and negative contractile effects of somatostatin-14 on rat ventricular cardiomyocytes. J Cardiovasc Pharmacol 2001; 37: 324-332.
35. Kaczynska K, Szereda-Przestaszewska M., Depressive cardio-respiratory effects of somatostatin in anaesthetized rats. Respir Physiol Neurobiol 2010; 170: 273-278.
36. Oberg K., Future aspects of somatostatin-receptor-mediated therapy. Neuroendocrinology 2004; 80 (Suppl 1): 57-61.
37. Chen W, Liang L, Ma T, et al. Role of hepatic stellate cells on graft injury after small-for-size liver transplantation. J Gastroenterol Hepatol 2011; 26: 1659-1668.
38. Kokudo N, Kothary PC, Eckhauser FE, Raper SE., Inhibitory effects of somatostatin on rat hepatocyte proliferation are mediated by cyclic AMP. J Surg Res 1991; 51: 113-118.
39. Kokudo N, Kothary PC, Eckhauser FE, Nakamura T, Raper SE., Inhibition of DNA synthesis by somatostatin in rat hepatocytes stimulated by hepatocyte growth factor or epidermal growth factor. Am J Surg 1992; 163: 169-173.
40. Kothary PC, Kokudo N, Eckhauser FE, DelValle J, Raper SE., Preferential suppression of insulin-stimulated proliferation of cultured hepatocytes by somatostatin: Evidence for receptor-mediated growth regulation. J Cell Biochem 1995; 59: 258-265.
41. Franco-Gou R, Peralta C, Massip-Salcedo M, Xaus C, Serafin A, Rosello-Catafau J., Protection of reduced-size liver for transplantation. Am J Transplant 2004; 4: 1408-1420.
42. Clavien PA, Oberkofler CE, Raptis DA, Lehmann K, Rickenbacher A, El-Badry AM., What is critical for liver surgery and partial liver transplantation: Size or quality ? Hepatology 2010; 52: 715-729.
43. Ninomiya M, Shirabe K, Terashi T, et al. Deceleration of regenerative response improves the outcome of rat with massive hepatectomy. Am J Transplant 2010; 10: 1580-1587.
44. Belghiti J, Liddo G, Raut V, et al. " Inherent limitations" in donors: Control matched study of consequences following a right hepatectomy for living donation and benign liver lesions. Ann Surg 2012; 255: 528-533.
45. Ninomiya M, Harada N, Shiotani S, et al. Hepatocyte growth factor and transforming growth factor beta1 contribute to regeneration of small-for-size liver graft immediately after transplantation. Transpl Int 2003; 16: 814-819.
46. Michalopoulos GK, DeFrances MC., Liver regeneration. Science 1997; 276: 60-66.
47. Taub R., Liver regeneration: From myth to mechanism. Nat Rev Mol Cell Biol 2004; 5: 836-847.
48. Martinez-Hernandez A, Amenta PS., The extracellular matrix in hepatic regeneration. FASEB J 1995; 9: 1401-1410.
49. Wack KE, Ross MA, Zegarra V, Sysko LR, Watkins SC, Stolz DB., Sinusoidal ultrastructure evaluated during the revascularization of regenerating rat liver. Hepatology 2001; 33: 363-378.
50. Ross MA, Sander CM, Kleeb TB, Watkins SC, Stolz DB., Spatiotemporal expression of angiogenesis growth factor receptors during the revascularization of regenerating rat liver. Hepatology 2001; 34: 1135-1148.
51. Tanaka A, Shinohara H, Hatano E, et al. Perioperative changes in hepatic function as assessed by asialoglycoprotein receptor indices by technetium 99m galactosyl human serum albumin. Hepatogastroenterology 1999; 46: 369-375.
52. Nadalin S, Testa G, Malago M, et al. Volumetric and functional recovery of the liver after right hepatectomy for living donation. Liver Transpl 2004; 10: 1024-1029.
53. Jochum C, Beste M, Penndorf V, et al. Quantitative liver function tests in donors and recipients of living donor liver transplantation. Liver Transpl 2006; 12: 544-549.
54. de Graaf W, Bennink RJ, Heger M, Maas A, de Bruin K, van Gulik TM., Quantitative assessment of hepatic function during liver regeneration in a standardized rat model. J Nucl Med 2011; 52: 294-302.